Viewing data from:

CIMETIDINE HYDROCHLORIDE

ANDA

CIMETIDINE HYDROCHLORIDE | A074296 | HOSPIRA INC

1 strength0 unique patents0 unique exclusivities

API Supply Chain0 active DMFs2 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

GEDEON RICHTER LTDInactiveCIMETIDINE HYDROCHLORIDE

DMF 97691992

CORDEN PHARMA BERGAMO SPAInactiveCIMETIDINE HYDROCHLORIDE

DMF 115831995

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 300MG BASE/2ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Mar 28, 1997

No patent or exclusivity listings for this strength.

Change History (2)

Recent changes detected for this application.

MODIFIEDApplicant7/1/2026

Hospira replaced Cosette as the applicant for cimetidine hydrochloride oral solution (NDA 074296).

Old: COSETTE

New: HOSPIRA

MODIFIEDApplicant Full Name7/1/2026

Hospira Inc acquired the NDA for cimetidine hydrochloride (NDA 074296) from Cosette Pharmaceuticals Inc.

Old: COSETTE PHARMACEUTICALS INC

New: HOSPIRA INC